William P. Forbes
EVP, Chief Development Officer at Heron Therapeutics · 16 reported transactions in 1 company · latest report Oct 19, 2026
Their trades
Shares withheld for tax | Oct 19, 2026 | |||
Exercised options | Oct 19, 2026 | |||
Shares withheld for tax | Jul 31, 2026 | |||
Exercised options | Jul 31, 2026 | |||
Shares withheld for tax | Jul 30, 2026 | |||
Exercised options | Jul 30, 2026 | |||
Shares withheld for tax | Jul 19, 2026 | |||
Exercised options | Jul 19, 2026 | |||
Exercised options | Jun 6, 2026 | |||
Exercised options | Jan 31, 2026 |